BioAtla (BCAB) Total Non-Current Liabilities (2020 - 2026)

BioAtla's Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $45.0 million for Q1 2026.

• On a quarterly basis, Total Non-Current Liabilities rose 25.75% year-over-year to $45.0 million in Q1 2026; TTM through Mar 2026 was $45.0 million, a 25.75% increase from a year earlier, with the FY2025 full-year figure at $46.5 million, up 153.4% from the prior year.
• Total Non-Current Liabilities slipped to $45.0 million in Q1 2026 per BCAB's latest filing, from $46.5 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $49.0 million in Q4 2023 and bottomed at $17.5 million in Q2 2024.
• The 5-year median for Total Non-Current Liabilities is $28.3 million (2023), against an average of $30.7 million.
• Across the five-year window, Total Non-Current Liabilities sank 62.54% in 2024 and jumped 153.4% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $25.6 million in 2022, then jumped by 91.42% to $49.0 million in 2023, then sank by 62.54% to $18.4 million in 2024, then soared by 153.4% to $46.5 million in 2025, then retreated by 3.16% to $45.0 million in 2026.
• Per Business Quant, the three latest BCAB Total Non-Current Liabilities figures stand at $45.0 million (Q1 2026), $46.5 million (Q4 2025), and $27.3 million (Q3 2025).